Abstract:To investigate the effects of interleukin (IL)-17-mediated autophagy on the TNF receptor associated factor (TRAF6)/extracellular signal-regulated kinase (ERK)/p38 pathway and osteoclast differentiation. Mouse bone marrow-derived macrophages (BMM) were cultured with a medium containing 30 ng/mL macrophage colony stimulating factor and 50 ng/mL receptor activator of nuclear factor-kappa B ligard (RANKL), and IL-17 (0.01, 0.1, 1.0, 10 ng/mL) was added for intervention (IL-17 group). Tartrate-resistant acid phosphatase (TRAP) staining was used to observe TRAP positive multinucleated cells; phalloidin fluorescent staining was used to detect actin ring circumference; toluidine blue staining was used to analyze bone resorption lacuna formation. To further examine the mechanism of the effect of IL-17-mediated autophagy on the differentiation of osteoclasts, the control group used RANKL medium to culture mouse macrophage RAW264.7 cells, while the IL-17 group was treated with IL-17 (0.01, 0.1, 1.0, /mL). Western blot was used to detect the expression of autophagy-related proteins Beclin-1, microtubule-associated protein 1 light chain 3 (LC3) and osteoclast-related proteins c-fos and nuclear factor of activated T cell 1 (NFATc1) after treatment with different concentrations of IL-17. The expression of LC3, NFATc1, TRAF6/ERK/p38 signaling pathway related proteins were detected in IL-17 and autophagy inhibitor 3-MA group. The number of TRAP positive multinucleated cells, the circumference of the actin ring and the area of bone resorption lacuna in IL-17 group treated with IL-17 (0.01, 0.1, were significantly higher than those in the control group. In IL-17 treated RAW264.7 cells, the expression of c-fos, NFATc1, Beclin-1, LC3, TRAF6, p-ERK, and p-p38 was all significantly up-regulated (all 0.05). After treatment with the autophagy inhibitor 3-MA, the expression levels of LC3, NFATc1, TRAF6, p-ERK, and p-p38 all decreased significantly (all 0.05). IL-17 can promote the expression of autophagy proteins and enhance the differentiation ability of osteoclast precursor cells, and the TRAF6/ERK/p38 signaling pathway may be involved in this process.

Effect of JAK2/STAT3 Signaling Pathway on RANKL-induced Osteoclastogenesis in RAW264.7 Cells

Isoalantolactone Inhibits RANKL-induced Osteoclast Formation Via Multiple Signaling Pathways

AG490 Inhibits NFATc1 Expression and STAT3 Activation During RANKL Induced Osteoclastogenesis.

PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

TRAF6/ERK/p38 Pathway is Involved in Interleukin-17-mediated Autophagy to Promote Osteoclast Precursor Cell Differentiation.

RANKL Downregulates Cell Surface CXCR6 Expression Through JAK2/STAT3 Signaling Pathway During Osteoclastogenesis

RANKL expression of primary osteoblasts is enhanced by an IL-17-mediated JAK2/STAT3 pathway through autophagy suppression

Crosstalk Between STAT3 and RANK Signaling Pathways During Osteoclastogenesis (174.7)

Effect of Interleukin-21 on Osteoclastogenesis in RAW264.7 Cells

Osteoclastogenesis in RAW264.7 Cells Induced by RANKL

The Role of Cannabinoid Receptor 2 Selective Antagonist in Osteoclast Differentiation of RAW264.7 Cells

Differentiation of osteoclast-like cells induced by using different concentrations of M-CSF and RANKL

Stattic Inhibits RANKL-mediated Osteoclastogenesis by Suppressing Activation of STAT3 and NF-κB Pathways.

Effect of radiation on the expression of osteoclast marker genes in RAW264.7 cells.

STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription

Cellular Study of the LPS-induced Osteoclastic Multinucleated Cell Formation from RAW264.7 Cells.

[Osteoclast Differentiation Regulated by Receptor Activator of Nuclear Factor Kappab Probably Through a Novel Signaling Pathway].

The effect of TGF-β on osteoclast differentiation in vitro

Evaluation of culture conditions for osteoclastogenesis in RAW264.7 cells

Xl019, a Novel JAK Inhibitor, Suppressed Osteoclasts Differentiation Induced by RANKL Through MAPK Signaling Pathway.